|
⚲
|
| Keyboard |
| Longwood Fund II LP
✚
|
|
|---|---|
| CIK # | 0001543245 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001543245] | |
| 4 | [0001543245] | |
| D | [0001543245] | |
| SC 13D | [0001543245] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Longwood Fund II LP | KalVista Pharmaceuticals Inc | [2017-10-20] |
| Longwood Fund II LP | Flex Pharma Inc | [2015-02-19] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Decoy Therapeutics Inc | |
| Longwood Fund II LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Decoy Therapeutics Inc FLKS
Common Stock
|
2018-10-16 | Sell | 3,212,861 | $0.92 | 2,955,832 |
|
Decoy Therapeutics Inc FLKS
Common Stock
|
2016-03-11 | Buy | 89,680 | $7.00 | 627,760 |
|
Decoy Therapeutics Inc FLKS
Common Stock
|
2015-02-03 | Conversion | 516,697 | $0.00 | |
|
Decoy Therapeutics Inc FLKS
Common Stock
|
2015-02-03 | Conversion | 1,868,067 | $0.00 | |
|
Decoy Therapeutics Inc FLKS
Series A Preferred Stock · derivative
|
2015-02-03 | Conversion | 8,000,000 | $0.00 | |
|
Decoy Therapeutics Inc FLKS
Series B Preferred Stock · derivative
|
2015-02-03 | Conversion | 2,212,756 | $0.00 |